FR EA

Extract to table

Pull the structured facts out of a document: parties, dates, amounts, obligations.

Extract to table / idr-06-response.docx
idr-06-response.docx · 1018-00009

Parties

HARKNESS LLP
Penterra Pharmaceuticals Corp
Penterra Manufacturing Ireland Ltd
Costs Inc
Altera Corp
Associates LLP
Whitmore Valuation Group LLC

Dates

August 18, 2022
June 8, 2022
July 14, 2022
July 1, 2012
March 15, 2012
December 31, 2020
July 6, 2022
July 12, 2022
September 15, 2022
June 20, 2022

Amounts

$312,000,000
$487.3
$598.4
$6,820,000,000
€2,140,000,000
$487,300,000
$523,800,000
$561,200,000
$598,400,000
$186,148,600

Obligations

482-7(e), each controlled participant's share of intangible development costs must be proportional to its share of the reasonably anticipated benefits ("RAB") attributable to the intangible development activities conducted under the CSA